Loading asset research
ImageneBio Inc. Common Stock
IMANasdaq · USD · StocksQuote as of · Exchange session not verified$5.08
+1.50%
Today
IMA
Loading 1D prices…
Market cap
$57.8M
Volume
8K
52w high
$9.2052w low
$3.94Company profile
ImageneBio Inc. Common Stock
ImageneBio, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for patients with immunological, autoimmune and inflammatory diseases. Its lead product candidate includes IMG-007, a non-depleting anti-OX40 monoclonal antibody that binds to OX40 receptor on activated T cells to block receptor binding to OX40 ligand which is in Phase 1b/2a clinical trial. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California.
Sector
Health Care
Industry
Biological Products, (No Diagnostic Substances)
Exchange
Nasdaq
Display currency
USD
Location
SAN DIEGO, CA, United States
Employees
18
Fiscal year end
1231
CIK
1835579
Session & valuation
Open$5.08
Previous close$5.01
Day high$5.14
Day low$4.93
30-day avg. volume12.2K
Outstanding shares11.4M
Diluted EPS-$9.64
Latest annual period
P/E (trailing)-0.53
P/E (forward)-1.18
Price / book0.40
Beta—
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2836
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| EXOZeXoZymes Inc. Common Stock | $58.5M | $0.00 | — | -$1.09 | +2.13% | Unrated |
| INKTMiNK Therapeutics Inc. Common Stock | $61.2M | $0.00 | — | -$2.93 | -1.07% | Buy |
| INMBINmune Bio Inc. Common stock | $61.6M | $50K | -92000.00% | -$1.86 | -3.90% | Buy |
| ELOXEloxx Pharmaceuticals Inc. Common Stock | $54.1M | $0.00 | — | -$5.34 | -3.26% | Buy |
| LONALeonaBio Inc. Common Stock | $65.2M | $0.00 | — | -$24.70 | +0.87% | Buy |